North America Nuclear Medicine Radiopharmaceuticals Market by Diagnostics (SPECT, PET), by Therapeutics (Beta Emitters, Alpha Emitters, Brachytherapy), by Application (cardiology, lymphoma, thyroid, neurology oncology) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2018–2023)

North America Nuclear Medicine Radiopharmaceuticals Market by Diagnostics (SPECT, PET), by Therapeutics (Beta Emitters, Alpha Emitters, Brachytherapy), by Application (cardiology, lymphoma, thyroid, neurology oncology) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2018–2023)

ID: 129 | Pages: 145 | April 2018 | Region: North America


Nuclear medicine falls under the field of Molecular imaging, which involves usage of minute amount of radioactive material (radiopharmaceuticals) to diagnose and treat disease.

North America market for nuclear medicine Radiopharmaceuticals is estimated at $2.23 billion in 2018 and is expected to reach $3.79 billion by 2023, growing at a CAGR of 11.2%.

Increasing incidence of chronic diseases such as cancer and cardiac ailments, huge technological advancements, escalating demand for SPECT and PET applications along with the growing public awareness for healthcare are the major factors fuelling the growth of Radiopharmaceuticals market. Further, Integration of X ray tomography (CT) into SPECT has recently emerged as an excellent diagnostic tool in medical imaging and is considered to be a driving factor for the growth of the market. Strict regulatory framework and reimbursement issues are the key factors blocking the growth of the market. In addition to the above factors shorter half-life of radiopharmaceuticals and competition from orthodox diagnostic procedures are also the key factors restraining the North America nuclear medicine Radioisotopes market.

The market of radiopharmaceuticals is segmented into Diagnostic radioisotopes and Therapeutic radioisotopes. Diagnostic radioisotope market basically covers SPECT (Technetium-99m, Thallium-201 Gallium-67, Iodine) and PET (Fluorine-18, Rubidium-82) radioisotopes. Therapeutic radioisotopes cover Beta emitters (Iodine-131, Yttrium-90, Samarium-153, Rhenium-186, Lutetium-177), Alpha Emitters (Radium-223) and Brachytherapy (Cesium-131, Iodine-125, Palladium-103, Iridium-192). By application market is segmented into (cardiology, lymphoma, thyroid, neurology oncology, and others). Furthermore, on the basis of geography, the North America market is analyzed two regions namely, USA and Canada.

Radiopharmaceuticals market is dominated by diagnostic radioisotopes with an estimated market share of 90 % while therapeutic radioisotopes contribute for around 10% of the market. Based on type of radioisotopes the market is segmented into Technetium-99m (TC-99m), Thallium-201 (TL-201), Fluorine-18, Iodine (I-123), Rubidium-82 (RB-82) and others. The F-18 market is mostly contributed by F-18 FDG tracers though this market is enriched with future tracers such as F-18 Florbetapir and F-18 Choline. The promising clinical outcomes of these tracers have gained the business interest of major research institutes and PET isotope players. Ga-68 and Rb-82 are two other potential isotopes in the PET diagnostic market, ensuring high growth of the diagnostics segment. Diagnosis of coronary artery disease, bone metastasis, and Alzheimer’s disease are the most promising indications for the future PET radioisotopes market. United States is the largest consumer market for radioisotopes and Canada is the largest producer of Tc-99m.

Some of the key players influencing the North America nuclear medicine market are GE Healthcare, Hologic Inc., Medix Inc., Segami Corporation,Positron Corporation,Bracco Imaging S.p.A, Naviscan Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc. and IBA Molecular Imaging.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                           

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                              

                2.2 Analysis Design                                         

                2.3 Research Phases                                      

                                2.3.1 Secondary Research                            

                                2.3.2 Primary Research                 

                                2.3.3 Econometric Modelling                     

                                2.3.4 Expert Validation                  

                2.4 Study Timeline                                          

3. Overview                                                      

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                      

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                                                              

                5.1 By Type                                        

                                5.1.1 Diagnostic Radioisotopes                 

                                                5.1.1.1 SPECT    

                                                                5.1.1.1.1 Technetium-99m

                                                                5.1.1.1.2 Thallium-201

                                                                5.1.1.1.3 Gallium-67

                                                                5.1.1.1.4 Iodine-23

                                                                5.1.1.1.5 Others

                                                5.1.1.2 PET         

                                                                5.1.1.2.1 Fluorine-18

                                                                5.1.1.2.2 Rubidium-82

                                                                5.1.1.2.3 Others

                                5.1.2 Therapeutic Radioisotopes                              

                                                5.1.2.1 Beta Emitters     

                                                                5.1.2.1.1 Iodine-131

                                                                5.1.2.1.2 Yttrium-90

                                                                5.1.2.1.3 Samarium-153

                                                                5.1.2.1.4 Rhenium-186

                                                                5.1.2.1.5 Lutetium-177

                                                5.1.2.2 Alpha Emitters   

                                                                5.1.2.2.1 Radium-223

                                                5.1.2.3 Brachytherapy   

                                                                5.1.2.3.1 Cesium-131

                                                                5.1.2.3.2 Iodine-125

                                                                5.1.2.3.3 Palladium-103

                                                                5.1.2.3.4 Iridium-192

                5.2 By Application                                           

                                5.2.1 Cardiology                               

                                5.2.2 Lymphoma                             

                                5.2.3 Thyroid                     

                                5.2.4 Neurology               

                                5.2.5 Oncology                 

                                5.2.6 Others                      

6. Geographical Analysis                                                              

                6.1 Introduction                                              

                6.2 United States                                            

                6.3 Canada                                         

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                      

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services               

                                7.2.5 Competitive Rivalry within the Industry                      

8.Market Leaders' Analysis                                                          

                8.1 GE Healthcare                                           

                                8.1.1 Overview                

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                            

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Hologic Inc.                                

                8.3 Segami Corporation                                

                8.4 Positron Corporation                                              

                8.5 Bracco Imaging S.P.A                                              

                8.6 Naviscan Inc.                                              

                8.7 Bayer Healthcare                                     

                8.8 Lantheus Medical Imaging Inc.                                           

                8.9 IBA Molecular Imaging                                           

                8.10 Medix Inc.                                

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                        

                9.3 Agreements, collaborations and Joint Ventures                                          

                9.4 New Product Launches                                          

10.Expert Opinions                                                         

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. North America Nuclear Medicine Radiopharmaceuticals Market By Region, From 2018-2023 (USD Million)
  2. North America Nuclear Medicine Radiopharmaceuticals Market By Type, From 2018-2023 (USD Million)
  3. North America Diagnostic Radioisotopes Market By Region, From 2018-2023 (USD Million)
  4. North America Therapeutic Radioisotopes Market By Region, From 2018-2023 (USD Million)
  5. North America Nuclear Medicine Radiopharmaceuticals Market By Application, From 2018-2023 (USD Million)
  6. North America Cardiology Market By Region, From 2018-2023 (USD Million)
  7. North America Lymphoma Market By Region, From 2018-2023 (USD Million)
  8. North America Thyroid Market By Region, From 2018-2023 (USD Million)
  9. North America Neurology Market By Region, From 2018-2023 (USD Million)
  10. North America Oncology Market By Region, From 2018-2023 (USD Million)
  11. North America Other Applications Market By Region, From 2018-2023 (USD Million)
  12. North America Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  13. North America SPECT Diagnostic Radioisotopes Market By Region, From 2018-2023 ( USD Million )
  14. North America PET Diagnostic Radioisotopes Market By Region, From 2018-2023 ( USD Million )
  15. North America Other Diagnostic Radioisotopes Market By Region, From 2018-2023 ( USD Million )
  16. North America SPECT Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  17. North America Technetium-99m Market By Region, From 2018-2023 ( USD Million )
  18. North America Thallium-201 Market By Region, From 2018-2023 ( USD Million )
  19. North America Gallium-67 Market By Region, From 2018-2023 ( USD Million )
  20. North America Iodine-23 Market By Region, From 2018-2023 ( USD Million )
  21. North America Other SPECT Diagnostic Radioisotopes Market By Region, From 2018-2023 ( USD Million )
  22. North America PET Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  23. North America Fluorine-18 Market By Region, From 2018-2023 ( USD Million )
  24. North America Rubidium-82 Market By Region, From 2018-2023 ( USD Million )
  25. North America Other PET Diagnostic Radioisotopes Market By Region, From 2018-2023 ( USD Million )
  26. North America Therapeutic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  27. North America Beta Emitters Market By Region, From 2018-2023 ( USD Million )
  28. North America Alpha Emitters Market By Region, From 2018-2023 ( USD Million )
  29. North America Brachytherapy Market By Region, From 2018-2023 ( USD Million )
  30. North America Beta Emitters Market By Type, From 2018-2023 ( USD Million )
  31. North America Iodine-131 Market By Region, From 2018-2023 ( USD Million )
  32. North America Yttrium-90 Market By Region, From 2018-2023 ( USD Million )
  33. North America Samarium-153 Market By Region, From 2018-2023 ( USD Million )
  34. North America Rhenium-186 Market By Region, From 2018-2023 ( USD Million )
  35. North America Lutetium-177 Market By Region, From 2018-2023 ( USD Million )
  36. North America Alpha Emitters Market By Type, From 2018-2023 ( USD Million )
  37. North America Radium-223 Market By Region, From 2018-2023 ( USD Million )
  38. North America Other Alpha Emitters Market By Region, From 2018-2023 ( USD Million )
  39. North America Brachytherapy Market By Type, From 2018-2023 ( USD Million )
  40. North America Cesium-131 Market By Region, From 2018-2023 ( USD Million )
  41. North America Iodine-125 Market By Region, From 2018-2023 ( USD Million )
  42. North America Palladium-103 Market By Region, From 2018-2023 ( USD Million )
  43. North America Iridium-192 Market By Region, From 2018-2023 ( USD Million )
  44. United States Nuclear Medicine Radiopharmaceuticals Market By Type, From 2018-2023 (USD Million)
  45. United States Nuclear Medicine Radiopharmaceuticals Market By Application, From 2018-2023 (USD Million)
  46. Canada Nuclear Medicine Radiopharmaceuticals Market By Type, From 2018-2023 (USD Million)
  47. Canada Nuclear Medicine Radiopharmaceuticals Market By Application, From 2018-2023 (USD Million)
  48. United States Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  49. Canada Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  50. United States SPECT Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  51. Canada SPECT Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  52. United States PET Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  53. Canada PET Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  54. United States Therapeutic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  55. Canada Therapeutic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  56. United States Beta Emitters Market By Type, From 2018-2023 ( USD Million )
  57. Canada Beta Emitters Market By Type, From 2018-2023 ( USD Million )
  58. United States Alpha Emitters Market By Type, From 2018-2023 ( USD Million )
  59. Canada Alpha Emitters Market By Type, From 2018-2023 ( USD Million )
  60. United States Brachytherapy Market By Type, From 2018-2023 ( USD Million )
  61. Canada Brachytherapy Market By Type, From 2018-2023 ( USD Million )
Middle East and Africa Microbial Identification Market by Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables...
Latin America Microbial Identification Market By Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instrum...
Asia-Pacific Microbial Identification Market By Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instrume...
Europe Microbial Identification Market By Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instruments), ...
North America Microbial Identification Market by Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instrum...
Microbial Identification Market by Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instruments), End Use...
Middle East & Africa Cell Harvesting Systems Market by Application (Bone Marrow, Umbilical Cord, Adipose Tissue, Peripheral Blood), by End-user (Academic Institutes, Hospitals, Diagnostic Labs, Research Centres), by...
Latin America Cell Harvesting Systems Market by Application (Bone Marrow, Umbilical Cord, Adipose Tissue, Peripheral Blood), by End-user (Academic Institutes, Hospitals, Diagnostic Labs, Research Centres), by Techni...
Asia Pacific Cell Harvesting Systems Market by Application (Bone Marrow, Umbilical Cord, Adipose Tissue, Peripheral Blood), by End-user (Academic Institutes, Hospitals, Diagnostic Labs, Research Centres), by Techniq...
Europe Cell Harvesting Systems Market By Application (Bone Marrow, Umbilical Cord, Adipose Tissue, Peripheral Blood), By End-user (Academic Institutes, Hospitals, Diagnostic Labs, Research Centers), By Techniques (B...
North America Cell Harvesting Systems Market by Application (Bone Marrow, Umbilical Cord, Adipose Tissue, Peripheral Blood), by End-user (Academic Institutes, Hospitals, Diagnostic Labs, Research Centres), by Techni...
Cell Harvesting Systems Market by Application (Bone Marrow, Umbilical Cord, Adipose Tissue, Peripheral Blood), by End-user (Academic Institutes, Hospitals, Diagnostic Labs, Research Centres), by Techniques (Blastome...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.